Dermatology, Drugs

Data Bridge Market Research United States of America United Kingdom

18.01.2023 - 19:32:52

Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research

Dermatology is a therapy area dealing with skin, hair, and nails diseases, where the most common conditions are psoriasis, eczema, and acne vulgaris. Dermatology drugs are used to manage and treat diseases related to skin, nail, hair, and genital membranes. 

The global dermatology drugs market is expected to witness significant growth during the forecast period. The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases is expected to see rise in the market growth. COVID-19 also had an impact on the market growth.

Dermatology Drugs Market Dynamics

Key Drivers

Rise in Clinical Studies

The dermatologicals market is expected to rise as more clinical studies are conducted to assess the efficacy and safety of a variety of medicinal medications. For instance, the pharmaceutical company Amgen Inc. announced the favourable findings of a phase 3 placebo-controlled, double-blind clinical research in December 2021. The trial's objective is to evaluate Otezla's effectiveness in managing moderate to severe psoriasis.


Increasing Elderly Population

The development of the dermatological pharmaceuticals market is fueled by the loss of human skin's ability to function properly with ageing, leading to numerous skin illnesses. Additionally, as we age, the body begins to experience several additional issues, including slower wound healing, increased sensitivity to ultraviolet (UV) radiation, increased susceptibility to infections, and decreased subcutaneous fat. Due to the increased likelihood of numerous skin conditions, the need for dermatological medications has skyrocketed.


High Cost

The huge expenditure associated with these drugs surely hamper the market growth. Several market players make huge investments in manufacturing new drugs to faster the recovery process; in return, the cost is increased.

Some of the major players operating in the Dermatology Drugs market are

LUPIN (India)Novartis AG (Switzerland)F. Hoffmann-La Roche Ltd (Switzerland)Pfizer Inc. (U.S.)Sanofi (France)Amgen inc. (U.S.)Lilly (U.S.)AstraZeneca (U.K.)AbbVie Inc (U.S.)Johnson & Johnson Private Limited (U.S.)LEO Pharma A/S (Denmark)Merck & Co., Inc (U.S.)Bausch Health Companies Inc (Canada)Bristol-Myers Squibb Company (U.S.)

Access Full PDF Research Report @

What benefits does DBMR Study is going to provide?

Latest industry influencing trends and development scenarioOpen up New MarketsTo Seize powerful market opportunitiesKey decision in planning and to further expand market shareIdentify Key Business Segments, Market proposition & Gap AnalysisAssisting in allocating marketing investments

Attractions of The Dermatology Drugs Market Report: -

Latest market dynamics, development trends and growth opportunities are presented along with industry barriers, developmental threats and risk factorsThe forecast Dermatology Drugs Market data will help in the feasibility analysis, market size estimation and developmentThe report serves as a complete guide which micro monitors all vital Dermatology Drugs MarketA concise market view will provide ease of understanding.Nut Oil Market Competitive market view will help the players in making a right move

The investment made in the study would provide you access to information such as:

Dermatology Drugs Industry [Global – Broken-down into regions]Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]Country wise Market Size Split [of important countries with major market share]Market Share and Revenue/Sales by leading playersMarket Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter's Five Forces, etc.Market SizeMarket Size by application/industry verticalsMarket Projections/Forecast

Browse Detailed Summary of Research Report @

Industry Segmentation:

By Dermatological Diseases

AcneDermatitisPsoriasisSkin Cancer

By Prescription mode

Prescription Based DrugsOver Counter Drugs

By Drug Classification

CorticosteroidsAstringentsAnti-Inflammatory & Antipruritic DrugsAnti-Infective/Antibacterial DrugsAntifungal Drugs

By Route of Administration

TopicalOralParenteral Administration

By Distribution Channel

Hospital PharmaciesRetail PharmaciesOnline Pharmacies

By End-User

HospitalsSpeciality ClinicsCosmetic Centres

Dermatology Drugs Market Regional Analysis/Insights

The global dermatology drugs market is analysed and market size insights and trends are provided by type, technology and end-user as referenced above.

The major countries covered in the Dermatology Drugs Industry Report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Europe and Asia-Pacific dominate the dermatology drugs market due to rising skin disease awareness, a growing number of patients suffering from acne, vitiligo, and dermatitis, a growing patient pool of a wide range of dermatological conditions, and patients' willingness to pay for expensive medications in these regions.


IntroductionMarket SegmentationExecutive SummaryPremium InsightsGlobal Dermatology Drugs Market: RegulationsMarket OverviewGlobal Dermatology Drugs Market, By Dermatological DiseasesGlobal Dermatology Drugs Market, By Prescription modeGlobal Dermatology Drugs Market, By Drug ClassificationGlobal Dermatology Drugs Market, By Route of AdministrationGlobal Dermatology Drugs Market, By Distribution ChannelGlobal Dermatology Drugs Market, By End-UserGlobal Dermatology Drugs Market: Company LandscapeSWOT AnalysesCompany ProfileQuestionnairesRelated Reports 

To Get Detailed Table of Content (TOC), please Click Here @

Browse Top Related Reports:

U.S. Dermatology Drugs Market, By Drug Class (Corticosteroids, Retinoids, Monoclonal Antibodies, Antibiotics Agent, Antiviral Agents, Antifungal Drugs, Antihistamines Agents, Immunosuppressive Drugs, Others), Drug Type (Branded, Generics), Prescription Mode (Prescription Based Drugs, Over-The-Counter Drugs), Indication (Infectious Skin Disease, Inflammatory/Autoimmune Disorders, Pigmentation Disorders, Skin Cancer, Others), Route of Administration (Topical, Oral, Parenteral), End User (Homecare, Hospitals, Dermatology Clinics, Others), Distribution Channel (Retail Pharmacy, Hospitals Pharmacy, Online Pharmacy, Others)

Asia-Pacific Dermatology Drugs Market , By Drug Class (Corticosteroids, Retinoids, Monoclonal Antibodies, Antibiotics Agent, Antiviral Agents, Antifungal Drugs, Antihistamines Agents, Immunosuppressive Drugs, Others), Drug Type (Branded, Generics), Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, Others), Prescription Mode (Prescription Based Drugs, Over-The-Counter Drugs), Route of Administration (Oral, Topical, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Antiplatelet Drugs Market, By Drug (Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Others), Indication (Myocardial Infraction, Percutaneous Coronary Interventions, Arterial Thrombosis, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Leprostatics Drugs Market, By Drug Type (Antibacterial, Leprostatics, Antitubercular, Antileprosy and Others), Treatment Type (Medication, Supportive Care, Multi Drug Therapy (MDT)), Route of Administration (Oral, Parenteral, Intravenous, Topical), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) 

Genitourinary Drugs Market, By Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence and Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Hematuria, Benign Prostatic Hyperplasia), Drug Type (Hormonal Therapy, Impotence Agents, Uterine Relaxants, Urinary Antispasmodics, Urinary pH Modifiers, Uterine Stimulants, Miscellaneous Genitourinary, Tract Agents) 

Bulbospinal Muscular Atrophy Drugs Market, By Drug Class (5?-Reductase Inhibitors (5-ARIs), Gonadotropin-releasing Hormone (GnRH) Agonists and Others), Drugs (Leuprorelin, Dutasteride and Others), Therapy (Physical Therapy, Occupational Therapy, and Speech Therapy), Treatment (Medication, Supportive Care and Surgery), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy)

Oral Nonsteroidal Anti-Inflammatory Drugs Market, By Type (Penicillins, Cephalosporins, Tetracyclins, Sulfonamides and Others), Treatment (Bactericidal, Bacteriostatic), Route of Administration (Oral, Parenteral, Others) 

Nucleic Acid Based Drugs Market, By Category (Antisense, siRNA, miRNA, Aptamer, Decoy, CpG-oilgo), Structure (Single Stranded DNA/RNA, Double Stranded DNA, Single-Stranded DNA, Others), Target (Transcriptor Factor, TLR9-Receptor, Protein), Mechanism (Inhibits the Physiological Effect, Adjuvant, Inhibits Transcription, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others) 

PEGylated Drugs Market, By Molecule (Protein, FAB' Fragment, Enzyme and Aptamer), Type (Interferons, Colony Stimulating Factors, Monoclonal Antibodies (mAbs), Other Types), Disease Indication (Gastrointestinal Disorders, Cancer, Multiple Sclerosis, Hepatitis, Other Disease Indications), Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others), Sales Channel (Hospital Pharmacy, Online Provider, Retail Pharmacy) Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475



Cision View original content: